HK Stock Market Move | TRANSTHERA-B(02617) fell more than 22%, halving from the day's high. The company stated that they are not aware of the reasons for the stock price and trading volume anomalies.

TRANSTHERA-B(02617) suddenly plunged, hitting a low of 320 Hong Kong dollars in the afternoon, down more than 50% from the intraday high of 679.5 Hong Kong dollars. As of the time of writing, it has dropped by 16.77% to 345.4 Hong Kong dollars, with a turnover of 2.879 billion Hong Kong dollars. On the news front, Pharmaron announced at noon today that the company's trading price and trading volume have recently experienced abnormal changes. The board of directors confirmed that they are not aware of any reasons that may have caused such abnormal changes in stock price and trading volume, or any information that needs to be disclosed to avoid a false market in the shares, or any insider information that needs to be disclosed according to listing rules. The board also confirmed that the business operations of the group are running normally, and there have been no significant changes in the business operations and financial condition of the group. Shareholders and potential investors are advised to exercise caution when trading the company's securities. It is worth noting that the Shanghai and Shenzhen stock exchanges recently announced that Pharmaron has been included in the list of eligible stocks for the Stock Connect program, effective from September 8. Data shows that since being included, institutional investors have continuously increased their positions in Pharmaron, with a total of 180 million and 142 million Hong Kong dollars added on September 12 and September 15 respectively. The stock hit a high of 679.5 Hong Kong dollars in today's trading, with a cumulative increase of nearly 10 times since being included in the program.